Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Vivek Chavda"'
Autor:
Vivek Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, Pankti Balar, Avinash Khadela, Dixa Vaghela, Shruti Soni, Charles R. Ashby Jr., Amit K. Tiwari
Publikováno v:
Cancer Reports, Vol 6, Iss S1, Pp n/a-n/a (2023)
Abstract Background Hepatocellular carcinoma (HCC) is a leading cause of cancer‐related death worldwide. The incidence of HCC is affected by genetic and non‐genetic factors. Genetically, mutations in the genes, tumor protein P53 (TP53), catenin b
Externí odkaz:
https://doaj.org/article/4424294178794a84942280b3f312f2b2
Autor:
Jiao Wang, Vivek Chavda, Riddhi Prajapati, Anjali Bedse, Jinita Patel, Sagar Popat, Gargi Jogi, Lakshmi Vineela Nalla, Keshava Jetha, Bairong Shen, Rajeev K. Singla
Publikováno v:
Current Research in Biotechnology, Vol 6, Iss , Pp 100159- (2023)
The pathogen SARS-CoV-2 has emerged and taken the shape of a global pandemic by causing COVID-19. SARS-CoV-2 has a very novel and unique set of genetic makeup that has created a puzzle in biological research. Therefore, the scientific community has n
Externí odkaz:
https://doaj.org/article/727c296c202d4ada8574bbbdfa465e2d
Publikováno v:
Metabolites, Vol 13, Iss 2, p 309 (2023)
The nucleoside analog β-D-N4-hydroxycytidine is the active metabolite of the prodrug molnupiravir and is accepted as an efficient drug against COVID-19. Molnupiravir targets the RNA-dependent RNA polymerase (RdRp) enzyme, which is responsible for re
Externí odkaz:
https://doaj.org/article/9dbe8a47b0f14296a04aede1bfee1084
Publikováno v:
Bioinformatics Tools for Pharmaceutical Drug Product Development. :95-116
Publikováno v:
Bioinformatics Tools for Pharmaceutical Drug Product Development. :77-93
Publikováno v:
Bioinformatics Tools for Pharmaceutical Drug Product Development. :37-54
Autor:
Vivek Chavda, Rajashri Bezbaruah, Disha Valu, Sanjay Desai, Nildip Chauhan, Swati Marwadi, Gitima Deka, Zhiyong Ding
Publikováno v:
Bioinformatics Tools for Pharmaceutical Drug Product Development. :117-145
Publikováno v:
Expert Review of Vaccines. 21:1537-1540
Autor:
Vivek Chavda, Toshika Mishra, Sathvika Kamaraj, Swati Punetha, Oishani Sengupta, Yash Joshi, Suneetha Vuppu, Dixa Vaghela, Lalitkumar Vora
Publikováno v:
Chavda, V P, Mishra, T, Kamaraj, S, Punetha, S, Sengupta, O, Joshi, Y, Vuppu, S, Vaghela, D & Vora, L 2023, ' Post-COVID-19 fungal infection in the aged population ', Vaccines, vol. 11, no. 3, 555 . https://doi.org/10.3390/vaccines11030555
Coronavirus disease 2019 (COVID-19) infection is currently a great cause of concern for the healthcare sector around the globe. SARS-CoV-2 is an RNA virus that causes a serious infection that is associated with numerous adverse effects and multiple c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::627195c1432fb8e4189adaa31cf13edc
https://pure.qub.ac.uk/en/publications/e5c59df6-af0e-437e-9c21-c5d046b1965c
https://pure.qub.ac.uk/en/publications/e5c59df6-af0e-437e-9c21-c5d046b1965c
Autor:
Vasso Apostolopoulos, Vivek Chavda
Publikováno v:
Expert Review of Vaccines. 21:597-600